InVivo Therapeutics and the New York Mets Present Spinal Cord Injury Awareness Day
InVivo Therapeutics Holdings Corp. (NVIV), a developer of
groundbreaking technologies for the treatment of spinal cord injuries
(SCI) and other neurotrauma conditions, today announced that the Company
is teaming with the New York Mets to create Major League Baseball’s
first Spinal Cord Injury Awareness Day on Sunday, September 15th at Citi
Field when the New York Mets take on the Miami Marlins at 1:10 p.m. ET.
InVivo has developed a treatment that uses a biocompatible polymer-based
scaffold to provide structural support to a damaged spinal cord in order
to spare tissue from scarring while improving recovery after a traumatic
SCI. The Company has received FDA approval to begin a first-in-man
clinical trial for the treatment of acute SCI which is expected to
commence in early fall.
InVivo will raise SCI awareness partly through an on-field donation to
the Greater New York Chapter of the National Spinal Cord Injury
Association (NSCIA) (www.nycspinalcord.org).
The check presentation will take place behind home plate immediately
prior to the start of the game. InVivo and the NSCIA will also be
recognized throughout the game and a public services announcement, along
with footage of the check presentation, will be re-aired during the game.
In addition, InVivo has donated the Modell’s Clubhouse to the NSCIA for
the game, which will give fans with SCI a very unique field level
experience. Information about SCI provided by the NSCIA will also be
available on the field level concourse by the Jackie Robinson Rotunda
throughout the game.
SCI is a devastating condition, and the average lifetime cost of care
for quadriplegic patients can exceed $6,200,000. InVivo would like to
encourage fans to give to local SCI fundraisers such as:
“The New York Mets have gone overboard to make sure this first SCI
Awareness Day at Citi Field will be amazing,” said InVivo CEO Frank
Reynolds. “We have donated more than a hundred tickets for people in
chairs to experience the Mets from the field, and we expect the day to
not only lead to a Mets win, but to a real uplifting of the human spirit
as SCI patients and families get to experience the understanding of New
York Mets fans.”
Tickets for Spinal Cord Injury Awareness Day can be purchased through www.Mets.com/InVivo
or by calling (718) 559-3131. Net proceeds from the day will go towards
helping people rebuild their lives after SCI by providing resources,
services, and peer support through the NSCIA. Fans purchasing tickets
through this offer will receive a Mets baseball cap and a 2013 Limited
Edition All-Star game pin.
About InVivo Therapeutics
InVivo Therapeutics Holdings Corp. is utilizing polymers as a platform
technology to develop treatments to improve function in individuals
paralyzed from traumatic spinal cord injuries. In 2011, the company
earned the prestigious David F. Apple Award from the American Spinal
Injury Association for its outstanding contribution to spinal cord
injury medicine. The publicly traded company (stock symbol NVIV) is
headquartered in Cambridge, MA. For more details, visit www.invivotherapeutics.com.
Safe Harbor Statement
Certain statements contained in this press release that are not
historical facts may constitute forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of
the Securities and Exchange Act of 1934, and the Company intends that
such statements are subject to the safe harbor created thereby. These
statements include, but are not limited to, those relating to the
potential up-listing of our common stock to a national securities
exchange, and the impact of any such up-listing, such as increasing
liquidity an unlocking inherent value in our stock. These
forward-looking statements are based on current expectations, but are
subject to a number of risks and uncertainties. The factors that could
cause actual future results to differ materially from current
expectations include, but are not limited to, risks and uncertainties
relating to the Company’s ability to up-list to a national securities
exchange, as well as other factors are identified and described in more
detail in our Annual Report on Form 10-K for the year ended December 31,
2012 and subsequent filings with the SEC.
Forward-looking statements contained in this press release speak only as
of the date of this release. Subsequent events or circumstances
occurring after such date may render these statements incomplete or out
of date. The Company undertakes no obligation and expressly disclaims
any duty to update such statements.
Copyright Business Wire 2013